Certified by Founder
Lodge
Epoch Biodesign
start up
United Kingdom
- London
- 22/06/2022
- Seed
- $11,000,000
Epoch is the Total BioDesign company developing natural solutions to unnatural problems. We are designing and scaling the first enzymes capable of transforming plastics into low-carbon, circular chemicals.
- Industry Biotechnology
- Website https://www.epochbiodesign.com/
- LinkedIn https://www.linkedin.com/company/epochbiodesign/
Navier AI | $6,500,000 | (Dec 17, 2025)
AIR Platforms | $6,100,000 | (Dec 17, 2025)
Auxira Health | $7,800,000 | (Dec 17, 2025)
Mirelo AI | $41,000,000 | (Dec 17, 2025)
Lucis (YC X25) | $8,500,000 | (Dec 17, 2025)
Verisoul | $8,800,000 | (Dec 17, 2025)
Aeovian Pharmaceuticals | $55,000,000 | (Dec 17, 2025)
Nanit | $50,000,000 | (Dec 17, 2025)
Culture Biosciences | Undisclosed Amount | (Dec 17, 2025)
YSE Beauty | $15,000,000 | (Dec 17, 2025)
Vital Lyfe | $24,000,000 | (Dec 17, 2025)
Dux Security | $9,000,000 | (Dec 17, 2025)